tangjz的个人主页 - 老虎社区

tangjz

暂无个人介绍

IP属地：北京

0关注

0粉丝

0主题

0勋章

03-14

b药明的退出，主要是避免游说时不必要的利益关联，恰恰代表bio将会尽更大努力代表行业进行游说

美知名组织BIO称正采取措施剔除药明康德会员资格，支持《生物安全法》

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4130202748360660","uuid":"4130202748360660","gmtCreate":1667099657021,"gmtModify":1667099657021,"name":"tangjz","pinyin":"tangjz","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":0,"tweetSize":1,"questionSize":0,"limitLevel":999,"accountStatus":2,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"北京","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":284133911257176,"gmtCreate":1710384970867,"gmtModify":1710385627648,"author":{"id":"4130202748360660","authorId":"4130202748360660","name":"tangjz","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130202748360660","authorIdStr":"4130202748360660"},"themes":[],"htmlText":"b药明的退出，主要是避免游说时不必要的利益关联，恰恰代表bio将会尽更大努力代表行业进行游说","listText":"b药明的退出，主要是避免游说时不必要的利益关联，恰恰代表bio将会尽更大努力代表行业进行游说","text":"b药明的退出，主要是避免游说时不必要的利益关联，恰恰代表bio将会尽更大努力代表行业进行游说","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/284133911257176","repostId":"1139973071","repostType":4,"repost":{"id":"1139973071","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1710384203,"share":"https://www.laohu8.com/m/news/1139973071?lang=&edition=full","pubTime":"2024-03-14 10:43","market":"hk","language":"zh","title":"美知名组织BIO称正采取措施剔除药明康德会员资格，支持《生物安全法》","url":"https://stock-news.laohu8.com/highlight/detail?id=1139973071","media":"老虎资讯综合","summary":"3月14日，今日在美国知名生物技术组织BIO（Biotechnology Innovation organization）官网获悉，BIO于美国时间3月13日发布一则新闻稿，称BIO目前正在采取措施，在组织成员资格方面与药明康德（WuXi-AppTec）分开，并表示将支持《生物安全法案》，并将随着该立法的进展与国会合作。在新闻稿中，BIO还透露其13日还致信众议院议员、美中战略竞争特别委员会主席迈克尔·加拉格尔（Michael Gallagher），表明其立场并强调生物技术行业对国家安全的重要性。小财注：药明康德曾是BIO长期会员，今日在医药股大涨情况下，药明系港股跌幅均在9%左右。","content":"<html><head></head><body><p>3月14日，今日在美国知名生物技术组织BIO（Biotechnology Innovation organization）官网获悉，BIO于美国时间3月13日发布一则新闻稿，称BIO目前正在采取措施，在组织成员资格方面与<a href=\"https://laohu8.com/S/603259\">药明康德</a>（WuXi-AppTec）分开，并表示将支持《生物安全法案》，并将随着该立法的进展与国会合作。在新闻稿中，BIO还透露其13日还致信众议院议员、美中战略竞争特别委员会主席迈克尔·加拉格尔（Michael Gallagher），表明其立场并强调生物技术行业对国家安全的重要性。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/44327aabce29b3b4e4bba028dfe35e1e\" title=\"\" tg-width=\"1192\" tg-height=\"486\"/></p><p>受此消息影响，今日港股药明系全线重挫，<a href=\"https://laohu8.com/S/02359\">药明康德</a>、<a href=\"https://laohu8.com/S/02269\">药明生物</a>、<a href=\"https://laohu8.com/S/02268\">药明合联</a>均跌超8%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/236125c7a37ef46bc9043969be4ea5f9\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6a6142f58719d3b42e41a5728bcf261\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ac291014da5e488a160c363039de6bfa\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美知名组织BIO称正采取措施剔除药明康德会员资格，支持《生物安全法》</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美知名组织BIO称正采取措施剔除药明康德会员资格，支持《生物安全法》\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2024-03-14 10:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>3月14日，今日在美国知名生物技术组织BIO（Biotechnology Innovation organization）官网获悉，BIO于美国时间3月13日发布一则新闻稿，称BIO目前正在采取措施，在组织成员资格方面与<a href=\"https://laohu8.com/S/603259\">药明康德</a>（WuXi-AppTec）分开，并表示将支持《生物安全法案》，并将随着该立法的进展与国会合作。在新闻稿中，BIO还透露其13日还致信众议院议员、美中战略竞争特别委员会主席迈克尔·加拉格尔（Michael Gallagher），表明其立场并强调生物技术行业对国家安全的重要性。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/44327aabce29b3b4e4bba028dfe35e1e\" title=\"\" tg-width=\"1192\" tg-height=\"486\"/></p><p>受此消息影响，今日港股药明系全线重挫，<a href=\"https://laohu8.com/S/02359\">药明康德</a>、<a href=\"https://laohu8.com/S/02269\">药明生物</a>、<a href=\"https://laohu8.com/S/02268\">药明合联</a>均跌超8%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/236125c7a37ef46bc9043969be4ea5f9\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6a6142f58719d3b42e41a5728bcf261\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ac291014da5e488a160c363039de6bfa\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","relate_stocks":{"603259":"药明康德","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","BK0216":"研究试验","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU0052750758.USD":"富兰克林中国基金A Acc","BIO":"Bio Rad实验室","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","LU1046422090.SGD":"Fidelity Pacific A-SGD","BK4585":"ETF&股票定投概念","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","BK1583":"高瓴概念","02359":"药明康德","LU1997245177.USD":"安联神洲A股基金","02268":"药明合联","BK4121":"生命科学工具和服务","02269":"药明生物","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","BK4588":"碎股"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139973071","content_text":"3月14日，今日在美国知名生物技术组织BIO（Biotechnology Innovation organization）官网获悉，BIO于美国时间3月13日发布一则新闻稿，称BIO目前正在采取措施，在组织成员资格方面与药明康德（WuXi-AppTec）分开，并表示将支持《生物安全法案》，并将随着该立法的进展与国会合作。在新闻稿中，BIO还透露其13日还致信众议院议员、美中战略竞争特别委员会主席迈克尔·加拉格尔（Michael Gallagher），表明其立场并强调生物技术行业对国家安全的重要性。受此消息影响，今日港股药明系全线重挫，药明康德、药明生物、药明合联均跌超8%。","news_type":1},"isVote":1,"tweetType":1,"viewCount":443,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":284133911257176,"gmtCreate":1710384970867,"gmtModify":1710385627648,"author":{"id":"4130202748360660","authorId":"4130202748360660","name":"tangjz","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130202748360660","authorIdStr":"4130202748360660"},"themes":[],"htmlText":"b药明的退出，主要是避免游说时不必要的利益关联，恰恰代表bio将会尽更大努力代表行业进行游说","listText":"b药明的退出，主要是避免游说时不必要的利益关联，恰恰代表bio将会尽更大努力代表行业进行游说","text":"b药明的退出，主要是避免游说时不必要的利益关联，恰恰代表bio将会尽更大努力代表行业进行游说","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/284133911257176","repostId":"1139973071","repostType":4,"repost":{"id":"1139973071","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1710384203,"share":"https://www.laohu8.com/m/news/1139973071?lang=&edition=full","pubTime":"2024-03-14 10:43","market":"hk","language":"zh","title":"美知名组织BIO称正采取措施剔除药明康德会员资格，支持《生物安全法》","url":"https://stock-news.laohu8.com/highlight/detail?id=1139973071","media":"老虎资讯综合","summary":"3月14日，今日在美国知名生物技术组织BIO（Biotechnology Innovation organization）官网获悉，BIO于美国时间3月13日发布一则新闻稿，称BIO目前正在采取措施，在组织成员资格方面与药明康德（WuXi-AppTec）分开，并表示将支持《生物安全法案》，并将随着该立法的进展与国会合作。在新闻稿中，BIO还透露其13日还致信众议院议员、美中战略竞争特别委员会主席迈克尔·加拉格尔（Michael Gallagher），表明其立场并强调生物技术行业对国家安全的重要性。小财注：药明康德曾是BIO长期会员，今日在医药股大涨情况下，药明系港股跌幅均在9%左右。","content":"<html><head></head><body><p>3月14日，今日在美国知名生物技术组织BIO（Biotechnology Innovation organization）官网获悉，BIO于美国时间3月13日发布一则新闻稿，称BIO目前正在采取措施，在组织成员资格方面与<a href=\"https://laohu8.com/S/603259\">药明康德</a>（WuXi-AppTec）分开，并表示将支持《生物安全法案》，并将随着该立法的进展与国会合作。在新闻稿中，BIO还透露其13日还致信众议院议员、美中战略竞争特别委员会主席迈克尔·加拉格尔（Michael Gallagher），表明其立场并强调生物技术行业对国家安全的重要性。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/44327aabce29b3b4e4bba028dfe35e1e\" title=\"\" tg-width=\"1192\" tg-height=\"486\"/></p><p>受此消息影响，今日港股药明系全线重挫，<a href=\"https://laohu8.com/S/02359\">药明康德</a>、<a href=\"https://laohu8.com/S/02269\">药明生物</a>、<a href=\"https://laohu8.com/S/02268\">药明合联</a>均跌超8%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/236125c7a37ef46bc9043969be4ea5f9\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6a6142f58719d3b42e41a5728bcf261\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ac291014da5e488a160c363039de6bfa\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美知名组织BIO称正采取措施剔除药明康德会员资格，支持《生物安全法》</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美知名组织BIO称正采取措施剔除药明康德会员资格，支持《生物安全法》\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2024-03-14 10:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>3月14日，今日在美国知名生物技术组织BIO（Biotechnology Innovation organization）官网获悉，BIO于美国时间3月13日发布一则新闻稿，称BIO目前正在采取措施，在组织成员资格方面与<a href=\"https://laohu8.com/S/603259\">药明康德</a>（WuXi-AppTec）分开，并表示将支持《生物安全法案》，并将随着该立法的进展与国会合作。在新闻稿中，BIO还透露其13日还致信众议院议员、美中战略竞争特别委员会主席迈克尔·加拉格尔（Michael Gallagher），表明其立场并强调生物技术行业对国家安全的重要性。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/44327aabce29b3b4e4bba028dfe35e1e\" title=\"\" tg-width=\"1192\" tg-height=\"486\"/></p><p>受此消息影响，今日港股药明系全线重挫，<a href=\"https://laohu8.com/S/02359\">药明康德</a>、<a href=\"https://laohu8.com/S/02269\">药明生物</a>、<a href=\"https://laohu8.com/S/02268\">药明合联</a>均跌超8%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/236125c7a37ef46bc9043969be4ea5f9\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6a6142f58719d3b42e41a5728bcf261\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ac291014da5e488a160c363039de6bfa\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","relate_stocks":{"603259":"药明康德","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","BK0216":"研究试验","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU0052750758.USD":"富兰克林中国基金A Acc","BIO":"Bio Rad实验室","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","LU1046422090.SGD":"Fidelity Pacific A-SGD","BK4585":"ETF&股票定投概念","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","BK1583":"高瓴概念","02359":"药明康德","LU1997245177.USD":"安联神洲A股基金","02268":"药明合联","BK4121":"生命科学工具和服务","02269":"药明生物","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","BK4588":"碎股"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139973071","content_text":"3月14日，今日在美国知名生物技术组织BIO（Biotechnology Innovation organization）官网获悉，BIO于美国时间3月13日发布一则新闻稿，称BIO目前正在采取措施，在组织成员资格方面与药明康德（WuXi-AppTec）分开，并表示将支持《生物安全法案》，并将随着该立法的进展与国会合作。在新闻稿中，BIO还透露其13日还致信众议院议员、美中战略竞争特别委员会主席迈克尔·加拉格尔（Michael Gallagher），表明其立场并强调生物技术行业对国家安全的重要性。受此消息影响，今日港股药明系全线重挫，药明康德、药明生物、药明合联均跌超8%。","news_type":1},"isVote":1,"tweetType":1,"viewCount":443,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}